TW202330902A - 免疫賦活化組合物 - Google Patents
免疫賦活化組合物 Download PDFInfo
- Publication number
- TW202330902A TW202330902A TW111145092A TW111145092A TW202330902A TW 202330902 A TW202330902 A TW 202330902A TW 111145092 A TW111145092 A TW 111145092A TW 111145092 A TW111145092 A TW 111145092A TW 202330902 A TW202330902 A TW 202330902A
- Authority
- TW
- Taiwan
- Prior art keywords
- cells
- cd11b
- composition
- expression
- iga
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 180
- 230000003308 immunostimulating effect Effects 0.000 title abstract description 4
- 210000003719 b-lymphocyte Anatomy 0.000 claims abstract description 446
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 claims abstract description 338
- 102100022338 Integrin alpha-M Human genes 0.000 claims abstract description 338
- 230000014509 gene expression Effects 0.000 claims abstract description 155
- 210000001280 germinal center Anatomy 0.000 claims abstract description 150
- 239000000126 substance Substances 0.000 claims abstract description 82
- 230000001939 inductive effect Effects 0.000 claims abstract description 65
- 238000000034 method Methods 0.000 claims abstract description 58
- 238000012423 maintenance Methods 0.000 claims abstract description 39
- 230000005012 migration Effects 0.000 claims abstract description 28
- 238000013508 migration Methods 0.000 claims abstract description 28
- 230000006872 improvement Effects 0.000 claims abstract description 12
- 239000000427 antigen Substances 0.000 claims description 105
- 108091007433 antigens Proteins 0.000 claims description 104
- 102000036639 antigens Human genes 0.000 claims description 104
- 235000013305 food Nutrition 0.000 claims description 53
- 241000894006 Bacteria Species 0.000 claims description 51
- 230000005934 immune activation Effects 0.000 claims description 41
- 241000588724 Escherichia coli Species 0.000 claims description 38
- 230000036541 health Effects 0.000 claims description 35
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 31
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 31
- 230000004913 activation Effects 0.000 claims description 27
- 230000001580 bacterial effect Effects 0.000 claims description 25
- 201000010099 disease Diseases 0.000 claims description 18
- 229960005486 vaccine Drugs 0.000 claims description 17
- 241001138501 Salmonella enterica Species 0.000 claims description 15
- 241000605059 Bacteroidetes Species 0.000 claims description 13
- 210000004443 dendritic cell Anatomy 0.000 claims description 12
- 208000035475 disorder Diseases 0.000 claims description 12
- 208000035473 Communicable disease Diseases 0.000 claims description 10
- 239000012646 vaccine adjuvant Substances 0.000 claims description 10
- 229940124931 vaccine adjuvant Drugs 0.000 claims description 10
- 241000606215 Bacteroides vulgatus Species 0.000 claims description 9
- 241000588747 Klebsiella pneumoniae Species 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 244000045947 parasite Species 0.000 claims description 7
- 230000003612 virological effect Effects 0.000 claims description 6
- 239000003674 animal food additive Substances 0.000 claims description 5
- 239000002778 food additive Substances 0.000 claims description 5
- 235000013373 food additive Nutrition 0.000 claims description 5
- 230000002538 fungal effect Effects 0.000 claims description 5
- 241000192128 Gammaproteobacteria Species 0.000 claims description 4
- 241000606125 Bacteroides Species 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 101150026046 iga gene Proteins 0.000 description 178
- 210000004027 cell Anatomy 0.000 description 104
- 210000001986 peyer's patch Anatomy 0.000 description 101
- 230000036039 immunity Effects 0.000 description 50
- 241000699670 Mus sp. Species 0.000 description 46
- 239000008194 pharmaceutical composition Substances 0.000 description 46
- 102100039341 Atrial natriuretic peptide receptor 2 Human genes 0.000 description 41
- 101710102159 Atrial natriuretic peptide receptor 2 Proteins 0.000 description 41
- 210000001519 tissue Anatomy 0.000 description 29
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 26
- 230000000638 stimulation Effects 0.000 description 26
- 238000000684 flow cytometry Methods 0.000 description 22
- 230000000968 intestinal effect Effects 0.000 description 21
- 210000000952 spleen Anatomy 0.000 description 21
- 239000002671 adjuvant Substances 0.000 description 20
- 230000000694 effects Effects 0.000 description 20
- 108090000623 proteins and genes Proteins 0.000 description 19
- 230000003393 splenic effect Effects 0.000 description 19
- 101001125026 Homo sapiens Nucleotide-binding oligomerization domain-containing protein 2 Proteins 0.000 description 17
- 102100029441 Nucleotide-binding oligomerization domain-containing protein 2 Human genes 0.000 description 17
- 102100024333 Toll-like receptor 2 Human genes 0.000 description 17
- 108010046016 Peanut Agglutinin Proteins 0.000 description 16
- 210000004877 mucosa Anatomy 0.000 description 16
- 239000003112 inhibitor Substances 0.000 description 15
- 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 14
- 238000000338 in vitro Methods 0.000 description 14
- 108010058846 Ovalbumin Proteins 0.000 description 13
- 238000010586 diagram Methods 0.000 description 13
- 239000003550 marker Substances 0.000 description 13
- 229940092253 ovalbumin Drugs 0.000 description 13
- 230000004044 response Effects 0.000 description 13
- 108020004465 16S ribosomal RNA Proteins 0.000 description 12
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 239000002953 phosphate buffered saline Substances 0.000 description 12
- 108091008875 B cell receptors Proteins 0.000 description 11
- 239000002158 endotoxin Substances 0.000 description 11
- 229920006008 lipopolysaccharide Polymers 0.000 description 11
- 230000009824 affinity maturation Effects 0.000 description 10
- 230000000295 complement effect Effects 0.000 description 10
- 230000006698 induction Effects 0.000 description 10
- 239000003446 ligand Substances 0.000 description 10
- 210000004400 mucous membrane Anatomy 0.000 description 10
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 9
- 102100039360 Toll-like receptor 4 Human genes 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 230000027455 binding Effects 0.000 description 9
- 210000001035 gastrointestinal tract Anatomy 0.000 description 9
- 210000004180 plasmocyte Anatomy 0.000 description 9
- 208000035143 Bacterial infection Diseases 0.000 description 8
- 206010017533 Fungal infection Diseases 0.000 description 8
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 8
- 208000031888 Mycoses Diseases 0.000 description 8
- 208000022362 bacterial infectious disease Diseases 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 210000001806 memory b lymphocyte Anatomy 0.000 description 8
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 7
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- 208000030852 Parasitic disease Diseases 0.000 description 7
- 102100027010 Toll-like receptor 1 Human genes 0.000 description 7
- 208000036142 Viral infection Diseases 0.000 description 7
- 235000019688 fish Nutrition 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000003753 real-time PCR Methods 0.000 description 7
- 230000011664 signaling Effects 0.000 description 7
- 230000009385 viral infection Effects 0.000 description 7
- 241000251468 Actinopterygii Species 0.000 description 6
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 6
- 241000186016 Bifidobacterium bifidum Species 0.000 description 6
- 101000763579 Homo sapiens Toll-like receptor 1 Proteins 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 241000192142 Proteobacteria Species 0.000 description 6
- 241000276699 Seriola Species 0.000 description 6
- 108091023040 Transcription factor Proteins 0.000 description 6
- 102000040945 Transcription factor Human genes 0.000 description 6
- 230000003213 activating effect Effects 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 230000003053 immunization Effects 0.000 description 6
- 238000002649 immunization Methods 0.000 description 6
- DAZSWUUAFHBCGE-KRWDZBQOSA-N n-[(2s)-3-methyl-1-oxo-1-pyrrolidin-1-ylbutan-2-yl]-3-phenylpropanamide Chemical compound N([C@@H](C(C)C)C(=O)N1CCCC1)C(=O)CCC1=CC=CC=C1 DAZSWUUAFHBCGE-KRWDZBQOSA-N 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 102100021631 B-cell lymphoma 6 protein Human genes 0.000 description 5
- 241000186012 Bifidobacterium breve Species 0.000 description 5
- 108010017009 CD11b Antigen Proteins 0.000 description 5
- 102000004354 CD11b Antigen Human genes 0.000 description 5
- 101000971234 Homo sapiens B-cell lymphoma 6 protein Proteins 0.000 description 5
- 241001417534 Lutjanidae Species 0.000 description 5
- 241000277331 Salmonidae Species 0.000 description 5
- 102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 5
- 230000007123 defense Effects 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 230000008944 intestinal immunity Effects 0.000 description 5
- 210000004698 lymphocyte Anatomy 0.000 description 5
- 210000003928 nasal cavity Anatomy 0.000 description 5
- 235000012149 noodles Nutrition 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000012552 review Methods 0.000 description 5
- 230000003595 spectral effect Effects 0.000 description 5
- 230000004936 stimulating effect Effects 0.000 description 5
- OEDPHAKKZGDBEV-GFPBKZJXSA-N (2s)-6-amino-2-[[(2s)-6-amino-2-[[(2s)-6-amino-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2r)-3-[2,3-di(hexadecanoyloxy)propylsulfanyl]-2-(hexadecanoylamino)propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoic acid Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CCCCCCCCCCCCCCC)CSCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC OEDPHAKKZGDBEV-GFPBKZJXSA-N 0.000 description 4
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 4
- 108010085238 Actins Proteins 0.000 description 4
- 101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 description 4
- 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 4
- 102100025390 Integrin beta-2 Human genes 0.000 description 4
- 241000286209 Phasianidae Species 0.000 description 4
- 239000012980 RPMI-1640 medium Substances 0.000 description 4
- 241001417495 Serranidae Species 0.000 description 4
- 108010090804 Streptavidin Proteins 0.000 description 4
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000010261 cell growth Effects 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 230000003325 follicular Effects 0.000 description 4
- 235000013376 functional food Nutrition 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 210000004347 intestinal mucosa Anatomy 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 210000002751 lymph Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000010208 microarray analysis Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 230000000392 somatic effect Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000002255 vaccination Methods 0.000 description 4
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 4
- 102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 3
- 241000473391 Archosargus rhomboidalis Species 0.000 description 3
- 108091012583 BCL2 Proteins 0.000 description 3
- 101100289995 Caenorhabditis elegans mac-1 gene Proteins 0.000 description 3
- 241000699800 Cricetinae Species 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 101100122567 Danio rerio gpr183a gene Proteins 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 108010040721 Flagellin Proteins 0.000 description 3
- 102100021245 G-protein coupled receptor 183 Human genes 0.000 description 3
- 101710101406 G-protein coupled receptor 183 Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 102100022297 Integrin alpha-X Human genes 0.000 description 3
- 206010027476 Metastases Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241001441724 Tetraodontidae Species 0.000 description 3
- 102000002689 Toll-like receptor Human genes 0.000 description 3
- 108020000411 Toll-like receptor Proteins 0.000 description 3
- 108010060888 Toll-like receptor 2 Proteins 0.000 description 3
- 241000223109 Trypanosoma cruzi Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 230000008614 cellular interaction Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 210000001102 germinal center b cell Anatomy 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 229960002751 imiquimod Drugs 0.000 description 3
- DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000028709 inflammatory response Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 230000009401 metastasis Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- -1 pam3CSK4 Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 235000021067 refined food Nutrition 0.000 description 3
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 3
- 235000015067 sauces Nutrition 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 3
- 230000010474 transient expression Effects 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GUAHPAJOXVYFON-ZETCQYMHSA-N (8S)-8-amino-7-oxononanoic acid zwitterion Chemical compound C[C@H](N)C(=O)CCCCCC(O)=O GUAHPAJOXVYFON-ZETCQYMHSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000881711 Acipenser sturio Species 0.000 description 2
- 239000012099 Alexa Fluor family Substances 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 241000272517 Anseriformes Species 0.000 description 2
- 241000269350 Anura Species 0.000 description 2
- 241001204796 Arius maculatus Species 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 241000237519 Bivalvia Species 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 102100026008 Breakpoint cluster region protein Human genes 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 241000282994 Cervidae Species 0.000 description 2
- 241000252203 Clupea harengus Species 0.000 description 2
- 241001454694 Clupeiformes Species 0.000 description 2
- 241000252185 Cobitidae Species 0.000 description 2
- 208000011231 Crohn disease Diseases 0.000 description 2
- 241000252230 Ctenopharyngodon idella Species 0.000 description 2
- 241000252233 Cyprinus carpio Species 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 241000723298 Dicentrarchus labrax Species 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 241001417516 Haemulidae Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 2
- 241000252234 Hypophthalmichthys nobilis Species 0.000 description 2
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 241000270322 Lepidosauria Species 0.000 description 2
- 102000043131 MHC class II family Human genes 0.000 description 2
- 108091054438 MHC class II family Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 2
- 241000699660 Mus musculus Species 0.000 description 2
- 101100381525 Mus musculus Bcl6 gene Proteins 0.000 description 2
- 241000282339 Mustela Species 0.000 description 2
- 241000237536 Mytilus edulis Species 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000237502 Ostreidae Species 0.000 description 2
- 241001417867 Pangasianodon gigas Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000237503 Pectinidae Species 0.000 description 2
- 108010013639 Peptidoglycan Proteins 0.000 description 2
- 241000269799 Perca fluviatilis Species 0.000 description 2
- 241000490567 Pinctada Species 0.000 description 2
- 241000861914 Plecoglossus altivelis Species 0.000 description 2
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 2
- 241000269978 Pleuronectiformes Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 241000269821 Scombridae Species 0.000 description 2
- 241000893636 Seriola lalandi Species 0.000 description 2
- 241000270295 Serpentes Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 241001441722 Takifugu rubripes Species 0.000 description 2
- 241000270666 Testudines Species 0.000 description 2
- 241000276707 Tilapia Species 0.000 description 2
- 102000008235 Toll-Like Receptor 9 Human genes 0.000 description 2
- 108010060818 Toll-Like Receptor 9 Proteins 0.000 description 2
- 102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 235000019513 anchovy Nutrition 0.000 description 2
- 230000005875 antibody response Effects 0.000 description 2
- 230000005784 autoimmunity Effects 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 241001233037 catfish Species 0.000 description 2
- 230000008783 cell intrinsic mechanism Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 235000020639 clam Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 230000003511 endothelial effect Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 210000000285 follicular dendritic cell Anatomy 0.000 description 2
- 239000013505 freshwater Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000012178 germinal center formation Effects 0.000 description 2
- 235000019514 herring Nutrition 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- 230000007124 immune defense Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000011503 in vivo imaging Methods 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 230000000366 juvenile effect Effects 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000021056 liquid food Nutrition 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 235000020640 mackerel Nutrition 0.000 description 2
- 238000002493 microarray Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 235000020638 mussel Nutrition 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 238000001543 one-way ANOVA Methods 0.000 description 2
- 235000020636 oyster Nutrition 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000007420 reactivation Effects 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 235000012045 salad Nutrition 0.000 description 2
- 235000020637 scallop Nutrition 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 235000011888 snacks Nutrition 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000012353 t test Methods 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 238000011830 transgenic mouse model Methods 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 108010029988 AICDA (activation-induced cytidine deaminase) Proteins 0.000 description 1
- 241001519451 Abramis brama Species 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 206010001935 American trypanosomiasis Diseases 0.000 description 1
- 108010028006 B-Cell Activating Factor Proteins 0.000 description 1
- 101000964894 Bos taurus 14-3-3 protein zeta/delta Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- 108010029697 CD40 Ligand Proteins 0.000 description 1
- 102100032937 CD40 ligand Human genes 0.000 description 1
- 241000283708 Capra aegagrus Species 0.000 description 1
- 102000006818 Cell Adhesion Molecule-1 Human genes 0.000 description 1
- 108010072135 Cell Adhesion Molecule-1 Proteins 0.000 description 1
- 208000024699 Chagas disease Diseases 0.000 description 1
- 241000725101 Clea Species 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 102000000311 Cytosine Deaminase Human genes 0.000 description 1
- 108010080611 Cytosine Deaminase Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 241000275449 Diplectrum formosum Species 0.000 description 1
- 102100036254 E3 SUMO-protein ligase PIAS2 Human genes 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010065713 Gastric Fistula Diseases 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101000824278 Homo sapiens Acyl-[acyl-carrier-protein] hydrolase Proteins 0.000 description 1
- 101001074629 Homo sapiens E3 SUMO-protein ligase PIAS2 Proteins 0.000 description 1
- 101001125032 Homo sapiens Nucleotide-binding oligomerization domain-containing protein 1 Proteins 0.000 description 1
- 101000620653 Homo sapiens Serine/threonine-protein phosphatase 5 Proteins 0.000 description 1
- 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 description 1
- 101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 description 1
- 101000669402 Homo sapiens Toll-like receptor 7 Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 101150087807 Itgam gene Proteins 0.000 description 1
- 241000755266 Kathetostoma giganteum Species 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 108010030317 Macrophage-1 Antigen Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 101000983125 Mus musculus Pancreatic prohormone Proteins 0.000 description 1
- 101000648740 Mus musculus Tumor necrosis factor Proteins 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- YDOATJUIIFWTKQ-UHFFFAOYSA-N N-[2-[1-[2-(2,3-dihydro-1H-inden-5-ylamino)-2-oxoethyl]benzimidazol-2-yl]ethyl]-N-methylbenzamide Chemical compound CN(CCc1nc2ccccc2n1CC(=O)Nc3ccc4CCCc4c3)C(=O)c5ccccc5 YDOATJUIIFWTKQ-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 102100029424 Nucleotide-binding oligomerization domain-containing protein 1 Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 102100022346 Serine/threonine-protein phosphatase 5 Human genes 0.000 description 1
- 102100022433 Single-stranded DNA cytosine deaminase Human genes 0.000 description 1
- 108010060889 Toll-like receptor 1 Proteins 0.000 description 1
- 102100024324 Toll-like receptor 3 Human genes 0.000 description 1
- 102100039357 Toll-like receptor 5 Human genes 0.000 description 1
- 102100039390 Toll-like receptor 7 Human genes 0.000 description 1
- 238000010162 Tukey test Methods 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 210000003815 abdominal wall Anatomy 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000003314 affinity selection Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- GMTYREVWZXJPLF-AFHUBHILSA-N butorphanol D-tartrate Chemical compound OC(=O)[C@@H](O)[C@H](O)C(O)=O.N1([C@@H]2CC3=CC=C(C=C3[C@@]3([C@]2(CCCC3)O)CC1)O)CC1CCC1 GMTYREVWZXJPLF-AFHUBHILSA-N 0.000 description 1
- 229960001590 butorphanol tartrate Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 230000006041 cell recruitment Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000014048 cultured milk product Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 206010012818 diffuse large B-cell lymphoma Diseases 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- LEEIJTHMHDMWLJ-CQSZACIVSA-N ethyl (6r)-6-[(2-chloro-4-fluorophenyl)sulfamoyl]cyclohexene-1-carboxylate Chemical compound CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)NC1=CC=C(F)C=C1Cl LEEIJTHMHDMWLJ-CQSZACIVSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000003269 fluorescent indicator Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 101150002378 gC gene Proteins 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000008348 humoral response Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006058 immune tolerance Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 238000002991 immunohistochemical analysis Methods 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000002809 long lived plasma cell Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- HRLIOXLXPOHXTA-UHFFFAOYSA-N medetomidine Chemical compound C=1C=CC(C)=C(C)C=1C(C)C1=CN=C[N]1 HRLIOXLXPOHXTA-UHFFFAOYSA-N 0.000 description 1
- 229960002140 medetomidine Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- DDLIGBOFAVUZHB-UHFFFAOYSA-N midazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NC=C2CN=C1C1=CC=CC=C1F DDLIGBOFAVUZHB-UHFFFAOYSA-N 0.000 description 1
- 229960003793 midazolam Drugs 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 230000008881 mucosal defense Effects 0.000 description 1
- 210000000066 myeloid cell Anatomy 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 238000011022 operating instruction Methods 0.000 description 1
- 229940126578 oral vaccine Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000016046 other dairy product Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000012342 propidium iodide staining Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000026267 regulation of growth Effects 0.000 description 1
- 230000006335 response to radiation Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- ZSDSQXJSNMTJDA-UHFFFAOYSA-N trifluralin Chemical compound CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O ZSDSQXJSNMTJDA-UHFFFAOYSA-N 0.000 description 1
- 238000007492 two-way ANOVA Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000000264 venule Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0266—Klebsiella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021-196561 | 2021-12-02 | ||
| JP2021196561 | 2021-12-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202330902A true TW202330902A (zh) | 2023-08-01 |
Family
ID=86612110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW111145092A TW202330902A (zh) | 2021-12-02 | 2022-11-24 | 免疫賦活化組合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250127889A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4442279A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7665047B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN118613283A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3239834A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202330902A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023100745A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5650780B2 (ja) * | 2012-04-04 | 2015-01-07 | 日東電工株式会社 | ワクチン組成物 |
| CN103961700A (zh) * | 2013-02-05 | 2014-08-06 | 日东电工株式会社 | 粘膜给予用疫苗组合物 |
| JP6977206B2 (ja) * | 2016-03-31 | 2021-12-08 | 富山県 | 自然免疫を活性化する粘膜ワクチン用アジュバント |
| CN109982695A (zh) * | 2016-08-18 | 2019-07-05 | 国立大学法人奈良先端科学技术大学院大学 | 免疫调节剂 |
| CN112105371B (zh) * | 2018-02-09 | 2024-12-17 | 内斯托尔株式会社 | 脂多糖控制性肠道细菌及其用途 |
-
2022
- 2022-11-24 US US18/715,570 patent/US20250127889A1/en active Pending
- 2022-11-24 CA CA3239834A patent/CA3239834A1/en active Pending
- 2022-11-24 EP EP22901178.8A patent/EP4442279A4/en active Pending
- 2022-11-24 TW TW111145092A patent/TW202330902A/zh unknown
- 2022-11-24 WO PCT/JP2022/043424 patent/WO2023100745A1/ja not_active Ceased
- 2022-11-24 CN CN202280090108.7A patent/CN118613283A/zh active Pending
- 2022-11-24 JP JP2023564923A patent/JP7665047B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN118613283A (zh) | 2024-09-06 |
| EP4442279A4 (en) | 2025-12-31 |
| JP7665047B2 (ja) | 2025-04-18 |
| JPWO2023100745A1 (cg-RX-API-DMAC7.html) | 2023-06-08 |
| CA3239834A1 (en) | 2023-06-08 |
| US20250127889A1 (en) | 2025-04-24 |
| EP4442279A1 (en) | 2024-10-09 |
| WO2023100745A1 (ja) | 2023-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Coico | Immunology: a short course | |
| Tegtmeyer et al. | Campylobacter virulence factors and molecular host–pathogen interactions | |
| Broom et al. | The role of the gut microbiome in shaping the immune system of chickens | |
| Hill et al. | Intestinal bacteria and the regulation of immune cell homeostasis | |
| JP6551944B2 (ja) | 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物 | |
| Iweala et al. | Immune privilege in the gut: the establishment and maintenance of non‐responsiveness to dietary antigens and commensal flora | |
| Kuhn et al. | IL-6 stimulates intestinal epithelial proliferation and repair after injury | |
| Kao et al. | Helicobacter pylori immune escape is mediated by dendritic cell–induced Treg skewing and Th17 suppression in mice | |
| CN105229142B (zh) | 免疫刺激剂 | |
| JP2021518414A (ja) | 細菌株を含む組成物 | |
| US20210069260A1 (en) | Use of Bacteroides fragilis in preparing drugs for inducing at least one of proliferation and accumulation of &#947;&#948; T cells | |
| US11602551B2 (en) | Use of inosine for the treatment of t-reg deficiency | |
| JP7665047B2 (ja) | 免疫賦活化組成物 | |
| Shah et al. | Increased susceptibility to Yersinia enterocolitica Infection of Tff2 deficient mice | |
| Geervliet | A window of opportunity: Modulation of the porcine gut microbiota and immune system by feed additives in early life | |
| Watts | The effect of early microbiome modification on immune development and function in broiler chickens | |
| Erny et al. | Interactions of the Gut Microbiota and the Innate Immune System | |
| JP2014095570A (ja) | セリアック病に関連する、ＣＤ３００ａ遺伝子欠損マウスおよびＣＤ３００ａ発現細胞の活性調節剤の使用、ならびにＣＤ３００ａ発現細胞の活性調節剤を含有する医薬品 | |
| Pietrasanta | PRENATAL ANTIBIOTIC THERAPY PREDISPOSES TO NEONATAL SEPSIS INDUCED BY E. COLI: A ROLE FOR BREAST MILK IGA? | |
| Brisbin et al. | Regulation of the intestinal immune system by commensal microbiota in avian and ruminant species. | |
| Schwarzer | Impact of Probiotic Bacteria on Allergic Sensitization in Type I Allergy Model | |
| Russell | Intestinal responses to Clostridium perfringens in broilers | |
| Ritchuay | Characterisation of PAMP-PRR interaction and the immune response in Nile tilapia | |
| Paynich | Mechanism by Which Commensal Bacteria Limit Inflammation | |
| Geis | REGULATORY T CELLS PROMOTE IL-17-DEPENDENT CARCINOGENIC IMMUNITY TO ENTEROTOXIGENIC BACTEROIDES FRAGILIS |